Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 1, 2010, Pages 86-88

  Majtan, Juraj ^a,b   Majtanova, Lubica ^b   Majtan, Viktor ^b  

^a Inst Zool Slovak Acad of Sci   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Drug resistance; Salmonella Typhimurium; Slovakia

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISK DIFFUSION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SLOVAKIA;

EID: 77955801946     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.04.009     Document Type: Article

References (19)

1. Anderson E.J., Ward Z.R., de Saxe M.J. Bacteriophage-typing designations of Salmonella Typhimurium. J. Hyg. (Lond.) 1977, 78:297-300.
2. Bertrand S., Weill F.X., Cloeckaert A., Vrints M., Mairiaux E., Praud K., Dierick K., Wildemauve C., Godard C., Butaye P., Imberechts H., Grimont P.A., Collard J.M. Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J. Clin. Microbiol. 2006, 44:2897-2903.
3. Boonmar S., Bangtrakulnonth A., Pornruangwong S., Samosornsuk S., Kaneko K., Ogawa M. Significant increase in antibiotic resistance of Salmonella isolates from human beings and chicken meat in Thailand. Vet. Microbiol. 1998, 62:73-80.
4. Cheung T.K., Chu Y.W., Chu M.Y., Ma C.H., Yung R.W., Kam K.M. Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J. Antimicrob. Chemother. 2005, 56:586-589.
5. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 15th informational supplement (M100-S15) 2005, CLSI, Wayne, PA.
6. Crump J.A., Kretsinger K., Gay K., Hoekstra R.M., Vugia D.J., Hurd S., Megginson S.D., Luedeman L.J., Shiferaw B., Hanna S.S., Joyce K.W., Mintz E.D., Angulo F.J. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicenter retrospective cohort study. Antimicrob. Agents Chemother. 2008, 52:1278-1284.
7. Dionisi A.M., Lucarelli C., Owczarek S., Luzzi I., Villa L. Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 2009, 53:4019-4021.
8. EFSA Panel on Biological Hazards Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA J. 2009, 7:1-78.
9. Fierer J., Swancutt M. Non-typhoid Salmonella: a review. Curr. Clin. Top. Infect. Dis. 2000, 20:134-157.
10. Giraud E., Brisabois A., Martel J.L., Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 1999, 43:2131-2137.
11. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., Zijlstra E.E., Heyderman R.S., Hart C.A., Molyneux M.E. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin. Infect. Dis. 2008, 46:963-969.
12. Lynch M.F., Blanton E.M., Polyak C., Vojdani J., Stevenson J., Medalla F., Barzilay E., Joyce K., Barrett T., Mintz E.D. Typhoid fever in the United States, 1999-2006. JAMA 2009, 302:859-865.
13. Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O'Brien S.J., Jones T.F., Fazil A., Hoekstra R.M. The global burden of nontyphoidal salmonella gastroenteritis. Clin. Infect. Dis. 2010, 50:882-889.
14. Meakins S., Fisher I.S., Berghold C., Gerner-Smidt P., Tschäpe H., Cormican M., Luzzi I., Schneider F., Wannett W., Coia J., Echeita A., Threlfall E.J., participants E.-n. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: a report from the Enter-net International Surveillance Network. Microb. Drug. Resist. 2008, 14:31-35.
15. Prabha Adhikari M.R., Baliga S. Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime. J. Assoc. Physicians India 2002, 50:428-429.
16. Stevenson J.E., Gay K., Barrett T.J., Medalla F., Chiller T.M., Angulo F.J. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob. Agents Chemother. 2007, 51:195-197.
17. Whichard J.M., Gay K., Stevenson J.E., Joyce K.J., Cooper K.L., Omondi M., Medalla F., Jacoby G.A., Barrett T.J. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg. Infect. Dis. 2007, 13:1681-1688.
18. Xia S., Hendriksen R.S., Xie Z., Huang L., Zhang J., Guo W., Xu B., Ran L., Aarestrup F.M. Molecular characterization and antimicrobial susceptibility of Salmonella isolates from infections in humans in Henan Province, China. J. Clin. Microbiol. 2009, 47:401-409.
19. Yan J.-J., Chiou C.-S., Lauderdale T.-L.Y., Tsai S.-H., Wu J.-J. Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. Emerg. Infect. Dis. 2005, 11:947-950.